Temozolomide for Injection

Product description

It is an oral chemotherapy drug. It is analkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.

Strength: 100mg

It has been approved by CFDA.

Read more

Specifications

Categories Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Temozolomide for Injection

Contact information

Address

Telephone

Website

View all contact information